July 3, 2017 / 12:08 PM / 20 days ago

BRIEF-Incyte says Japan Ministry of Health, Labor And Welfare grants marketing approval for Olumiant

1 Min Read

July 3 (Reuters) - Incyte Corp

* Japan ministry of health, labor and welfare (mhlw) grants marketing approval for olumiant® (baricitinib) for the treatment of rheumatoid arthritis

* Incyte- ‍japan marketing authorization of olumiant triggers $15 million milestone payment from lilly to co, which co expects to recognize, in full,in q3 2017​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below